Research and experimental development on natural sciences and engineering
NACAMED AS
Revenue 2024
NOK 3.1m
Operating profit
NOK 1.3m
Equity
NOK 3.6m
Incorporated
2017
Share capital
NOK 137,000
Key figures · 2024
Current ratio
0.68
Equity ratio
63.3%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 39.9% | |
| Net margin (%%) | 41.0% | |
| Return on assets (%%) | 22.3% | |
| Likviditet | ||
| Current ratio | 0.68 | |
| Working capital | −670k | |
| Soliditet | ||
| Equity ratio (%%) | 63.3% | |
| Debt-to-equity ratio | 0.58 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.